Showing results (121-130 of 231) with videos related to
Sort By:
Pageof 24
BMC Infectious Diseases|January 9, 2020
Case report: meningitis as a presenting feature of anti-NMDA receptor encephalitisMaria Stavrou, Jing Ming Yeo, Alexander David Slater, et al.International Journal of Dermatology|November 26, 2009
Long-term efalizumab therapy for patients with moderate-to-severe, chronic plaque psoriasis: results from an Australian expanded access programPeter Foley, Michael Freeman, Kurt Gebauer, et al.Journal of Drugs in Dermatology : JDD|December 3, 2011
A comparison of cryotherapy and imiquimod for treatment of actinic keratoses: lesion clearance, safety, and skin quality outcomesPeter Foley, Kate Merlin, Simon Cumming, et al.Archives of Dermatology|February 21, 2007
National Psoriasis Foundation clinical consensus on disease severityDavid M Pariser, Jerry Bagel, Joel M Gelfand, et al.The Australasian Journal of Dermatology|January 18, 2026
Targeted Systemic Therapies for Atopic Dermatitis in Australia: A Narrative ReviewDiana Rubel, Peter Foley, Kathryn A Gibson, et al.The Australasian Journal of Dermatology|July 9, 2022
Secukinumab treatment demonstrated high drug survival and sustained effectiveness in patients with severe chronic plaque psoriasis: 21-month analysis in Australian routine clinical practice (SUSTAIN study)Peter Foley, Nick Manuelpillai, Con Dolianitis, et al.The Journal of Dermatological Treatment|July 16, 2019
Guselkumab improves work productivity in patients with moderate-to-severe psoriasis with or without depression and anxiety: results from the VOYAGE 2 comparator study versus adalimumabKristian Reich, Peter Foley, Chenglong Han, et al.The Australasian Journal of Dermatology|July 18, 2002
Efficacy, cutaneous tolerance and cosmetic acceptability of desonide 0.05% lotion (Desowen) versus vehicle in the short-term treatment of facial atopic or seborrhoeic dermatitisSusanne Freeman, Anne Howard, Peter Foley, et al.Journal of the American Academy of Dermatology|February 9, 2016
Comparative effectiveness of biologic agents for the treatment of psoriasis in a real-world setting: Results from a large, prospective, observational study (Psoriasis Longitudinal Assessment and Registry [PSOLAR])Bruce E Strober, Robert Bissonnette, David Fiorentino, et al.The Australasian Journal of Dermatology|April 29, 2009
Successful treatment of lymphomatoid papulosis with photodynamic therapyMichelle Rodrigues, Christopher McCormack, Lee-Mei Yap, et al.Pageof 24